Infectious Diseases and Therapy

PubMed-indexed, rapid publication, peer reviewed #openaccess journal. Impact Factor 4.7. CiteScore 8.6. Part of @AdisJournals.

[Infectious Diseases and Therapy @InfectDis_Ther]

Costs and Outcomes of Clostridioides difficile Infections in Germany: A Retrospective Health Claims Data Analysis. Read the full article here: https://t.co/F4lRP1HrUU

[Infectious Diseases and Therapy @InfectDis_Ther]

Association of Antibiotic Route and Outcomes in Children with Methicillin-Resistant Staphylococcus aureus Bacteremic Osteomyelitis. Read the full article here: https://t.co/qi1L0aUX21

[Infectious Diseases and Therapy @InfectDis_Ther]

Leveraging Real-World Evidence to Define Severe RSV Lower Respiratory Tract Disease in Adults. Read the full article here: https://t.co/cYXDPeYc9c

[Infectious Diseases and Therapy @InfectDis_Ther]

Our latest review explores the characteristics and uses of endolysins derived from staphylococcal bacteriophages, as well as their antibacterial effectiveness against Staphylococcus spp. Read the full article here: https://t.co/MkYaFOeYVa

[Infectious Diseases and Therapy @InfectDis_Ther]

COVID-19 Vaccination Recommendations for Immunocompromised Patient Populations: Delphi Panel and Consensus Statement Generation in the United States
#COVIDー19

Read the full article #OpenAccess here:
https://t.co/OcNGYTXDUn

[Infectious Diseases and Therapy @InfectDis_Ther]

Bridging the Gap: Delphi Consensus Statements for SARS-CoV-2 Vaccination in Immunocompromised Patients
#COVIDー19

Read the full article #openaccess here:
https://t.co/IGPnUl5sE7

[Infectious Diseases and Therapy @InfectDis_Ther]

Modeling the Impact of Ensitrelvir on SARS-CoV-2 Dynamics and Its Application for Assessment of Transmission Mitigation of Patients with COVID-19: https://t.co/B89nb03tVD

[Infectious Diseases and Therapy @InfectDis_Ther]

This study, just published in Infectious Diseases and Therapy, evaluated the value-based price of the RSVpreF vaccine for pregnant people used for prevention of RSV-LRTI among infants in Argentina: https://t.co/65x1znwf2z

[Infectious Diseases and Therapy @InfectDis_Ther]

Navigating the Current Treatment Landscape of Metallo-β-Lactamase-Producing Gram-Negative Infections: What are the Limitations? https://t.co/4A83kMkE6V

[Infectious Diseases and Therapy @InfectDis_Ther]

Combination Versus Monotherapy for Carbapenem-Resistant Acinetobacter Species Serious Infections: A Prospective IPTW Adjusted Cohort Study: https://t.co/DusmpxUyFH

[Infectious Diseases and Therapy @InfectDis_Ther]

Acute Cerebellitis Following COVID-19: Alarming Clinical Presentation Challenged by Normal Paraclinical Findings: https://t.co/2lBU3FLiyj

[Infectious Diseases and Therapy @InfectDis_Ther]

Influenza-Associated Excess Mortality and Hospitalization in Germany from 1996 to 2018: https://t.co/VrTaFJMKNu

[Infectious Diseases and Therapy @InfectDis_Ther]

Disease Burden Associated with All Infants in Their First RSV Season in the UK: A Static Model of Universal Immunization with Nirsevimab Against RSV-Related Outcomes
https://t.co/78gIPhPL9l

[Infectious Diseases and Therapy @InfectDis_Ther]

Efficacy and Safety of Low-Dose, Rapidly Infused Bamlanivimab and Etesevimab: Phase 3 BLAZE-1 Trial for Mild-to-Moderate COVID-19: https://t.co/78gIPhPL9l

[Infectious Diseases and Therapy @InfectDis_Ther]

Mycoplasma hominis as Cause of Extragenital Infection in Patients with Hypogammaglobulinemia: Report of 2 Cases and Literature Review: https://t.co/q6auO3mb0F

[Infectious Diseases and Therapy @InfectDis_Ther]

The latest piece of research published in Infectious Diseases and Therapy looked at the extracorporeal removal of cytokines from the bloodstream, and the potential of this therapy to help in treating septic shock. More here: https://t.co/YDOQB9TpGt

[Infectious Diseases and Therapy @InfectDis_Ther]

New research just published in Infectious Diseases and Therapy describes a model which estimated the cost benefits of using the antiviral drug baloxavir, compared to oseltamivir or no treatment for #influenza patients.

https://t.co/gXwY5p1hdu

[Infectious Diseases and Therapy @InfectDis_Ther]

How do we define long-COVID for better research, diagnostics and treatment? In this commentary, just published in Infectious Diseases & Therapy, the authors propose refinement into three sub-groups - read more here:

https://t.co/foPgtazAf0

[Infectious Diseases and Therapy @InfectDis_Ther]

"#Safety, #Tolerability, and #Pharmacokinetics of Nebulized GB05-Human IFNα1b Inhalation Solution: A Randomized, Placebo-Controlled, Dose-Escalation Phase I Study in Healthy Chinese Adult Volunteers"

https://t.co/vGoN2I87nd

#RespiratorySyncytialVirus #RSV

[Infectious Diseases and Therapy @InfectDis_Ther]

"Proportion of Patients in the United States Who Fill Their Nirmatrelvir/Ritonavir Prescriptions"

Available #openaccess here: https://t.co/UXqA8BihDO

#covid19 #infectiousdiseases